BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18214621)

  • 1. Reasons for explantation of totally implantable access ports: a multivariate analysis of 385 consecutive patients.
    Fischer L; Knebel P; Schröder S; Bruckner T; Diener MK; Hennes R; Buhl K; Schmied B; Seiler CM
    Ann Surg Oncol; 2008 Apr; 15(4):1124-9. PubMed ID: 18214621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical technique for totally implantable access ports (TIAP) needs improvement: a multivariate analysis of 400 patients.
    Seiler CM; Frohlich BE; Dorsam UJ; Kienle P; Buchler MW; Knaebel HP
    J Surg Oncol; 2006 Jan; 93(1):24-9. PubMed ID: 16353193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications and risk factors of infection in pediatric hemato-oncology patients with totally implantable access ports (TIAPs).
    Nam SH; Kim DY; Kim SC; Kim IK
    Pediatr Blood Cancer; 2010 Apr; 54(4):546-51. PubMed ID: 19967773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Central venous totally implantable access for high dose chemotherapy in children].
    Conter C; Carausu L; Martin E; Rubie H; Castex MP; Marec-Berard P
    Arch Pediatr; 2006 Mar; 13(3):256-61. PubMed ID: 16469486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An 11-year retrospective study of totally implanted central venous access ports: complications and patient satisfaction.
    Ignatov A; Hoffman O; Smith B; Fahlke J; Peters B; Bischoff J; Costa SD
    Eur J Surg Oncol; 2009 Mar; 35(3):241-6. PubMed ID: 18329836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low complication rates with totally implantable access port use in epoprostenol treatment of pulmonary hypertension.
    Dickinson MG; Schölvinck EH; Boonstra A; Vonk-Noordegraaf A; Snijder RJ; Berger RM
    J Heart Lung Transplant; 2009 Mar; 28(3):273-9. PubMed ID: 19285620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The late complications of totally implantable central venous access ports: the results from an Italian multicenter prospective observation study.
    Dal Molin A; Rasero L; Guerretta L; Perfetti E; Clerico M
    Eur J Oncol Nurs; 2011 Dec; 15(5):377-81. PubMed ID: 21167777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A safe and effective method to implant a totally implantable access port in patients with synchronous bilateral mastectomies: modified femoral vein approach.
    Chen SY; Lin CH; Chang HM; Hsu HM; Yu JC
    J Surg Oncol; 2008 Sep; 98(3):197-9. PubMed ID: 18704915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Spectrum of indications and perioperative management in i. v. port-a-cath explantation--alternative administration of taurolin in case of i. v. port-a-cath infection].
    Weber M; Meyer F; Halloul Z
    Zentralbl Chir; 2009 Aug; 134(4):350-6. PubMed ID: 19688684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Incidence, prevalence and risk factors for a first infectious complication on a totally implantable venous-access port].
    Crisinel M; Mahy S; Ortega-Debalon P; Buisson M; Favre JP; Chavanet P; Piroth L
    Med Mal Infect; 2009 Apr; 39(4):252-8. PubMed ID: 19108966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients' attitudes to totally implantable venous access port systems for gynecological or breast malignancies.
    Kreis H; Loehberg CR; Lux MP; Ackermann S; Lang W; Beckmann MW; Fasching PA
    Eur J Surg Oncol; 2007 Feb; 33(1):39-43. PubMed ID: 17029869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications associated with the use of Port-a-Caths in patients with malignant or haematological disease: a single-centre prospective analysis.
    Heibl C; Trommet V; Burgstaller S; Mayrbaeurl B; Baldinger C; Koplmüller R; Kühr T; Wimmer L; Thaler J
    Eur J Cancer Care (Engl); 2010 Sep; 19(5):676-81. PubMed ID: 19708941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of totally implantable central venous access port via the basilic vein in patients with thoracic malignancies.
    Sonobe M; Chen F; Fujinaga T; Sato K; Shoji T; Sakai H; Miyahara R; Bando T; Okubo K; Hirata T; Date H
    Int J Clin Oncol; 2009 Jun; 14(3):208-12. PubMed ID: 19593611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trigger arrhythmia to confirm the position of totally implantable access ports (TIAP).
    Hsieh HF; Yu JC; Chuang CH; Wu HS; Tsai YC; Lin CH
    J Surg Oncol; 2007 Oct; 96(5):436-7. PubMed ID: 17372925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardized procedure prevents perioperative and early complications in totally implantable venous-access ports-a complication analysis of more than 1000 TIVAP implantations.
    Thiel K; Kalmbach S; Maier G; Wichmann D; Schenk M; Königsrainer A; Thiel C
    Langenbecks Arch Surg; 2022 Dec; 407(8):3755-3762. PubMed ID: 36070032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infectious port complications are more frequent in younger patients with hematologic malignancies than in solid tumor patients.
    Samaras P; Dold S; Braun J; Kestenholz P; Breitenstein S; Imhof A; Renner C; Stenner-Liewen F; Pestalozzi BC
    Oncology; 2008; 74(3-4):237-44. PubMed ID: 18716418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the Implantation Technique for Totally Implantable Venous Access Ports (TIVAPs) Influence Long-Term Outcome?
    Biacchi D; Sammartino P; Sibio S; Accarpio F; Cardi M; Sapienza P; De Cesare A; Atta JM; Impagnatiello A; Di Giorgio A
    World J Surg; 2016 Feb; 40(2):284-90. PubMed ID: 26341511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged interval in prophylactic heparin flushing for maintenance of subcutaneous implanted port care in patients with cancer.
    Kefeli U; Dane F; Yumuk PF; Karamanoglu A; Iyikesici S; Basaran G; Turhal NS
    Eur J Cancer Care (Engl); 2009 Mar; 18(2):191-4. PubMed ID: 19267736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Totally implantable venous access ports: a clinical trial comparing percutaneous versus surgical technique.
    Riapisarda C; Lanteri R; Santangelo M; Li Destri G; Di Cataldo A; Licata A
    Chir Ital; 2006; 58(3):305-8. PubMed ID: 16845866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Complications after insertion of a totally implantable venous access port in patients treated with chemotherapy for head and neck squamous cell carcinoma].
    Hoareau-Gruchet F; Rtail R; Sulaj H; Khirnetkina A; Reyt E; Righini CA
    Ann Otolaryngol Chir Cervicofac; 2009 Apr; 126(2):43-52. PubMed ID: 19324328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.